POST Online Media Lite Edition


Teva switches legal counsel after Mylan challenge

Staff writer |
Teva Pharmaceutical Industries has changed the law firm after a court sided with Mylan's bid to seek a preliminary injunction against the previous law firm.

Teva is now working with Sullivan & Cromwell LLP as legal counsel in its proposal to acquire Mylan, the Israeli drugmaker said Tuesday. It was previously working with another law firm, Kirkland & Ellis LLP.

A U.S. federal court had earlier on Tuesday recommended that a preliminary injunction be issued to disqualify Kirkland from advising Teva because that law firm already had an existing relationship with Mylan.

Kirkland stepped aside to avoid potential distractions, according to a person briefed on the matter who was not authorized to discuss the relationship between the law firm and Teva publicly.

The U.S. District Court for the Western District of Pennsylvania, in Pittsburgh, said the relationship between Kirkland and Mylan, which dates back to January 2013, made it impermissible for the law firm to represent Teva as it could harm Mylan's interests.

What to read next

Mylan wants to block Teva, Teva wants to block Mylan
Teva completes purchase of 4.61% interest in Mylan
Teva willing to give $31 billion for Mylan